Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel

Perspective > Medscape Diabetes & Endocrinology > Peters on Diabetes

COMMENTARY

Does COVID-19 Raise the Risk for Diabetes?

Anne L. Peters, MD

Disclosures

May 17, 2022

Download Slides

To continue reading this article ...

Continue reading your article with a Medscape account

Join the Top Medical Resource for Physicians Today. Free Membership!

Recommendations

2001
'Profound Implications': COVID Ups Diabetes Risk 40% a Year Later

Tables

Authors and Disclosures

Author(s)

Anne L. Peters, MD

Professor, Department of Clinical Medicine, Keck School of Medicine; Director, University of Southern California Westside Center for Diabetes, University of Southern California, Los Angeles, California

Disclosure: Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Abbott Diabetes Care; Becton Dickinson; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Lexicon Pharmaceuticals, Inc.; Livongo; Medscape; Merck & Co., Inc.; Novo Nordisk; Omada Health; OptumHealth; sanofi; Zafgen
Received research support from: Dexcom; MannKind Corporation; Astra Zeneca
Serve(d) as a member of a speakers bureau for: Novo Nordisk

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

Does COVID-19 Raise the Risk for Diabetes?

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Anne L. Peters, MD

Comments

Most Popular Articles

Email This

Feedback